Diagnostic and prognostic impact of serum-soluble UL16-binding protein 2 in lung cancer patients.
Yamaguchi K, Chikumi H, Shimizu A, Takata M, Kinoshita N, Hashimoto K, Nakamoto M, Matsunaga S, Kurai J, Miyake N, Matsumoto S, Watanabe M, Yamasaki A, Igishi T, Burioka N, Shimizu E.
Yamaguchi K, et al. Among authors: shimizu e, shimizu a.
Cancer Sci. 2012 Aug;103(8):1405-13. doi: 10.1111/j.1349-7006.2012.02330.x. Epub 2012 Jul 10.
Cancer Sci. 2012.
PMID: 22587355
Free PMC article.